| Members |
targetComponentId |
| Therapeutic endoscopic operations on outlet of female bladder |
Transurethral incision of neck of urinary bladder (procedure) |
| Therapeutic endoscopic procedure |
Endoscopic procedure |
| Therapeutic endoscopic retrograde operation on pancreatic duct NOS |
Endoscopic retrograde cholangiopancreatography (procedure) |
| Therapeutic endoscopy of urethra |
Endoscopy of urethra (procedure) |
| Therapeutic endoscopy on urethra NOS |
Endoscopy of urethra (procedure) |
| Therapeutic enteroscopy (& ileoscopy) |
Operative endoscopy of ileum |
| Therapeutic fiberoptic esophagoscopy |
Endoscopy of esophagus |
| Therapeutic injection into turbinates |
Injection of drug or medicament into nasal turbinate |
| Therapeutic injection of botulinum toxin |
Injection of botulinum toxin (procedure) |
| Therapeutic injection of botulinum toxin |
Injection of botulinum toxin (procedure) |
| Therapeutic injection of sinus tract |
Injection |
| Therapeutic percutaneous operation on gallbladder NOS |
Operation on gallbladder |
| Therapeutic percutaneous operation on pancreas |
Operation on pancreas |
| Therapeutic percutaneous operation on pancreas NOS |
Operation on pancreas |
| Therapeutic percutaneous operations on gallbladder |
Operation on gallbladder |
| Therapeutic prescription |
Prescription |
| Therapeutic prescription |
Prescription given (situation) |
| Therapeutic prescription NOS |
Prescription given (situation) |
| Therapeutic prescription NOS |
Prescription given (situation) |
| Therapeutic procedure on soft tissue |
Procedure on soft tissue |
| Therapeutic proctoscopy |
Proctoscopy |
| Therapeutic proctoscopy NOS |
Proctoscopy |
| Therapeutic puncture of cisterna magna |
Cisternal tap |
| Therapeutic rigid esophagoscopy |
Rigid esophagoscopy |
| Therapy-related acute myeloid leukemia and myelodysplastic syndrome, alkylating agent-related type |
Myeloid neoplasm post cytotoxic therapy (morphologic abnormality) |
| Thermoactinomyces candidus |
Thermoactinomyces vulgaris |
| Thermoactinomyces sacchari |
Laceyella sacchari (organism) |
| Thermoactinomyces thalpophilus |
Laceyella sacchari (organism) |
| Thermography - lymph nodes |
Lymph gland thermography |
| Thermomonospora formosensis |
Actinomadura formosensis (organism) |
| Thermomycolin |
Thermomycolin |
| Thiamine preparation allergy |
Allergy to thiamine (finding) |
| Thiazole dye |
Thiazole (substance) |
| Thigh flap |
Flap (substance) |
| Thigh random pattern flap |
Random pattern flap |
| Thigh sprain |
Sprain of hip |
| Thinning |
Decreased thickness |
| Thioether hydrolase |
Thioether hydrolase |
| Thiolester hydrolase |
Thiolester hydrolase |
| Thioridazine 10mg/5mL syrup |
Thioridazine 2 mg/mL oral solution |
| Thioridazine 50mg/5mL conventional release oral solution |
Product containing precisely thioridazine hydrochloride 10 milligram/1 milliliter conventional release oral solution (clinical drug) |
| Thioridazine 50mg/5mL s/f oral solution |
Product containing precisely thioridazine hydrochloride 10 milligram/1 milliliter conventional release oral solution (clinical drug) |
| Thioridazine hydrochloride 30mg/ml conventional release oral solution |
Thioridazine 30 mg/mL oral solution |
| Thioridazine hydrochloride 30mg/ml oral concentrate |
Thioridazine 30 mg/mL oral solution |
| Thiothixene hydrochloride 5mg powder for injection solution vial |
Product containing only tiotixene in parenteral dose form (medicinal product form) |
| Thiothixene hydrochloride 5mg/mL oral solution |
Tiotixene 5 mg/mL oral solution |
| Third degree atrioventricular block |
Complete atrioventricular block |
| Third diphtheria and tetanus double vaccination |
Administration of third dose of diphtheria and tetanus vaccine |
| Third diphtheria and tetanus double vaccination |
Administration of third dose of diphtheria and tetanus vaccine |
| Third diphtheria, pertussis and tetanus triple vaccination |
Administration of third dose of diphtheria, pertussis, and tetanus vaccine |
| Third diphtheria, pertussis and tetanus triple vaccination |
Administration of third dose of diphtheria, pertussis, and tetanus vaccine |
| Thoracic discography |
Discography with injection of contrast into intervertebral disc of thoracic spine (procedure) |
| Thoracic mesothelioma TNM finding |
American Joint Committee on Cancer allowable value |
| Thoracic somatic dysfunction |
Somatic dysfunction of thoracic region (finding) |
| Thoracoabdominal aortic aneurysm, without mention of rupture |
Thoracoabdominal aortic aneurysm |
| Thorny headed worm |
Phylum Acanthocephala (organism) |
| Thousands/microliter |
x10^3/microliter |
| Threatened abortion (antepartum) |
Threatened miscarriage |
| Threatened abortion - delivered |
Threatened miscarriage |
| Threatened abortion, unspecified as to episode of care |
Threatened miscarriage |
| Three hundred and sixty degree translocation of macula |
Translocation of retina (procedure) |
| Three previous induced terminations of pregnancy |
Past pregnancy history of multiple induced termination of pregnancy |
| Throat anti-infective preparation |
Product manufactured as oromucosal dose form (product) |
| Throat preparation |
Product manufactured as oromucosal dose form (product) |
| Thrombocytopenia: [congenital purpura] or [hereditary NEC] |
Hereditary thrombocytopenic disorder (disorder) |
| Thrombophilia due to acquired protein C deficiency |
Acquired protein C deficiency (disorder) |
| Thrombophilia due to acquired protein S deficiency |
Acquired protein S deficiency |
| Thrombosis of renal vein |
Thrombosis of renal vein |
| Thrombotic microangiopathy NOS |
Thrombotic microangiopathy (disorder) |
| Thrombus due to any device, implant AND/OR graft |
Thrombosis (disorder) |
| Thumb pulp flap |
Flap (substance) |
| Thymoma - category |
Thymoma |
| Thymoma, no International Classification of Diseases for Oncology subtype |
Thymoma of uncertain behaviour |
| Thymoma, type A |
Thymoma, type A, malignant |
| Thymoma, type AB |
Thymoma, type AB, malignant |
| Thymoma, type B1 |
Thymoma, type B1, malignant |
| Thymoma, type B2 |
Thymoma, type B2, malignant |
| Thymoma, type B3 |
Thymoma, type B3, malignant |
| Thymosin alpha 1 1.6mg powder for conventional release solution for injection vial |
Product containing only thymalfasin (medicinal product) |
| Thymosin alpha 1 1.6mg powder for injection solution vial + diluent |
Product containing only thymalfasin (medicinal product) |
| Thymoxamine 0.5% conventional release eye drops |
Product containing only moxisylyte in ocular dose form (medicinal product form) |
| Thymoxamine 0.5% preservative-free eye drops |
Product containing only moxisylyte in ocular dose form (medicinal product form) |
| Thyroid TNM finding |
American Joint Committee on Cancer allowable value |
| Thyroid eye disease with exophthalmos |
Exophthalmos due to thyroid eye disease (disorder) |
| Thyroid eye disease with strabismus |
Exophthalmos due to thyroid eye disease (disorder) |
| Thyroid gland excision |
Thyroidectomy |
| Thyroid related antibody |
Thyroid antibody |
| Thyrotropin alfa 0.9mg/mL powder for injection solution vial |
Thyrotrophin only product |
| Thyrotropin alfa 1.1mg/vial powder |
Thyrotrophin only product |
| Thyroxine sodium 100micrograms tablet |
Levothyroxine sodium anhydrous 100 microgram oral tablet |
| Thyroxine sodium 25micrograms tablet |
Product containing precisely levothyroxine sodium anhydrous 25 microgram/1 each conventional release oral tablet (clinical drug) |
| Thyroxine sodium 50micrograms tablet |
Levothyroxine sodium anhydrous 50 microgram oral tablet |
| Ticarcillin 3g/clavulanic acid 100mg powder for injection solution vial |
Product containing precisely clavulanic acid (as clavulanate potassium) 100 milligram and ticarcillin (as ticarcillin disodium) 3 gram/1 vial powder for conventional release solution for injection (clinical drug) |
| Ticarcillin disodium 1g powder for injection solution vial |
Product containing precisely ticarcillin (as ticarcillin disodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) |
| Ticarcillin disodium 20g powder for injection solution vial |
Product containing precisely ticarcillin (as ticarcillin disodium) 20 gram/1 vial powder for conventional release solution for injection (clinical drug) |
| Ticarcillin disodium 3g powder for injection solution vial |
Product containing precisely ticarcillin (as ticarcillin disodium) 3 gram/1 vial powder for conventional release solution for injection (clinical drug) |
| Tiludronate disodium |
Product containing tiludronic acid (medicinal product) |
| Time since symptom started NOS |
Symptom findings in relation to start time |
| Time since symptom started NOS |
Symptom findings in relation to start time |
| Time symptom lasts NOS |
Symptom findings in relation to time lasts (finding) |
| Time symptom lasts NOS |
Time symptom lasts |
FHIR